Preoperative Transarterial Chemoembolization for Laparoscopic Liver Resection in Child A Cirrhotic Patients with Hepatocellular Carcinoma
Overview
Authors
Affiliations
Purpose: Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding.
Methods: This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared.
Results: A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes.
Conclusion: In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
Liu B, Yang J, Wu Y, Chen X, Wu X Front Oncol. 2025; 14():1423549.
PMID: 39834934 PMC: 11743610. DOI: 10.3389/fonc.2024.1423549.
Lopez-Lopez V, Kalt F, Zhong J, Guidetti C, Magistri P, Di Benedetto F Langenbecks Arch Surg. 2024; 409(1):277.
PMID: 39269544 PMC: 11399194. DOI: 10.1007/s00423-024-03466-x.
Liu X, Qiu Z, Ndhlovu E, Wan Y, Sun H, Wang S J Hepatocell Carcinoma. 2024; 11:1127-1141.
PMID: 38895590 PMC: 11185261. DOI: 10.2147/JHC.S465670.
A systematic review and meta-analysis of blood transfusion rates during liver resection by country.
Kim S, Jung Y, Lee K, Kim K, Kim H, Choi D Ann Surg Treat Res. 2023; 105(6):404-416.
PMID: 38076606 PMC: 10703584. DOI: 10.4174/astr.2023.105.6.404.
Chen L, Zhang W, Sun T, Ren Y, Sun B, Zhu L J Hepatocell Carcinoma. 2022; 9:783-797.
PMID: 35983562 PMC: 9380831. DOI: 10.2147/JHC.S370486.